What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

Thromb Haemost. 2011 Apr;105(4):574-8. doi: 10.1160/TH10-12-0808. Epub 2011 Jan 12.
No abstract available

MeSH terms

  • Administration, Oral
  • Aged
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Benzimidazoles / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Dabigatran
  • Female
  • Humans
  • Male
  • Morpholines / therapeutic use*
  • Practice Guidelines as Topic
  • Pyrazoles / therapeutic use*
  • Pyridones / therapeutic use*
  • Rivaroxaban
  • Stroke / prevention & control
  • Thiophenes / therapeutic use*
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridones
  • Thiophenes
  • beta-Alanine
  • apixaban
  • Rivaroxaban
  • Dabigatran